Filter Results:
(8,552)
Show Results For
- All HBS Web
(8,552)
- People (32)
- News (1,481)
- Research (5,627)
- Events (36)
- Multimedia (31)
- Faculty Publications (3,785)
Show Results For
- All HBS Web
(8,552)
- People (32)
- News (1,481)
- Research (5,627)
- Events (36)
- Multimedia (31)
- Faculty Publications (3,785)
- January 1986 (Revised March 1997)
- Case
Horizon Group
Contains a description of a situation confronting the co-founder of a company planning to produce software for microcomputers. The company has just completed raising money from some wealthy investors by forming an R&D Limited Partnership. Development of the program (an... View Details
Keywords: Business or Company Management; Venture Capital; Partners and Partnerships; Business Plan; Outcome or Result; Research and Development; Financial Strategy; Corporate Finance; Information Technology Industry
Sahlman, William A. "Horizon Group." Harvard Business School Case 286-058, January 1986. (Revised March 1997.)
- July 1999 (Revised January 2004)
- Case
Chrysler and BMW: Tritec Engine Joint Venture
By: H. Kent Bowen and Courtney Purrington
A gifted project leader lacks significant new product development experience. The case highlights the issues and procedures related to defining the project strategy: organizing senior management approvals and support for creating a "heavyweight" team; aligning the... View Details
Keywords: Product Development; Joint Ventures; Projects; Business Strategy; Management Teams; Groups and Teams; Machinery and Machining; Design; Business Processes; Product Design; Product; Management Analysis, Tools, and Techniques; Auto Industry
Bowen, H. Kent, and Courtney Purrington. "Chrysler and BMW: Tritec Engine Joint Venture." Harvard Business School Case 600-004, July 1999. (Revised January 2004.)
- July 2001 (Revised August 2005)
- Case
Medicines Company, The
It is early 2001 and the Medicines Co. just received FDA approval to market Angiomax, a blood thinner to be used during angioplasties and heart procedures. It is intended to be a better alternative to Heparin, an 80-year-old drug that costs less then $10 per dose. The... View Details
Keywords: Business Model; Change Management; Decision Choices and Conditions; Cost Management; Price; Product Marketing; Product Launch; Product Development; Risk and Uncertainty; Health Industry; Pharmaceutical Industry
Gourville, John T. "Medicines Company, The." Harvard Business School Case 502-006, July 2001. (Revised August 2005.)
- October 2002
- Case
A Father's Love: Novazyme Pharmaceuticals, Inc.
By: Richard M.J. Bohmer and Bradley Campbell
John Crowley, CEO of Novazyme Pharmaceuticals, a start-up biotechnology firm developing an orphan drug to treat a rare lysosomal storage disorder from which his children suffer, must choose between a partnership and a buyout to have sufficient funds and support to get... View Details
Keywords: Technological Innovation; Business Startups; Partners and Partnerships; Financing and Loans; Governing Rules, Regulations, and Reforms; Sales; Price; Product Development; Motivation and Incentives; Decision Choices and Conditions; Biotechnology Industry; Pharmaceutical Industry
Bohmer, Richard M.J., and Bradley Campbell. "A Father's Love: Novazyme Pharmaceuticals, Inc." Harvard Business School Case 603-048, October 2002.
- November 2003 (Revised April 2010)
- Case
Flextronics International, Ltd.
By: Robert S. Huckman and Gary P. Pisano
Describes Flextronics' evolution from providing outsourced manufacturing services for original equipment manufacturers (OEMs) in the electronics industry to developing entire unbranded products for purchase by OEMs. In 2001, Flextronics began a development program that... View Details
Keywords: Growth and Development Strategy; Product Development; Production; Service Operations; Performance Effectiveness; Electronics Industry; Manufacturing Industry
Huckman, Robert S., and Gary P. Pisano. "Flextronics International, Ltd." Harvard Business School Case 604-063, November 2003. (Revised April 2010.)
- March 1994 (Revised March 1995)
- Case
Astra/Merck Group
By: Frank V. Cespedes and Marie Bell
Astra/Merck (A/M), originally a joint venture of AB Astra and Merck & Co., is preparing to be an independent company in 1993. Since the company does not engage in basic research and development of drugs, it is essentially a distribution organization. Fundamental to... View Details
Keywords: Cost vs Benefits; Marketing Strategy; Distribution; Performance Evaluation; Research and Development; Risk and Uncertainty; Sales; Competitive Strategy; Pharmaceutical Industry
Cespedes, Frank V., and Marie Bell. "Astra/Merck Group." Harvard Business School Case 594-045, March 1994. (Revised March 1995.)
- June 2004 (Revised June 2006)
- Supplement
Vertex Pharmaceuticals: R&D Portfolio Management (A)
By: Gary P. Pisano, Lee Fleming and Eli Strick
Vertex Pharmaceuticals, Inc., a drug discovery company that recently decided to pursue a vertically integrated business model, chose to build up its clinical development and commercial capabilities and infrastructure. For the first time in its history, Vertex will... View Details
Pisano, Gary P., Lee Fleming, and Eli Strick. "Vertex Pharmaceuticals: R&D Portfolio Management (A)." Harvard Business School Supplement 604-101, June 2004. (Revised June 2006.)
- August 1997
- Background Note
Accounting for Manufacturing Companies
By: Srikant M. Datar
The accounting for a manufacturing company is examined, including the flow of costs from raw materials to work in process to finished goods and the distribution between an inventoriable or product cost and a noninventoriable or period cost. View Details
Keywords: Cost Accounting; Product; Cost; Distribution; Accrual Accounting; Accounting; Manufacturing Industry
Datar, Srikant M. "Accounting for Manufacturing Companies." Harvard Business School Background Note 198-019, August 1997.
- 04 Oct 2004
- What Do You Think?
Does Speed Trump Intellectual Property?
introduced the idea of IP as not sustainable as a competitive advantage ... . It is knowledge that allows speed to trump IP." As E. Hassen put it, "Intellectual property is not just about product but View Details
Keywords: by James Heskett
- Career Coach
Ben Schlatka
Ben (HBS '05) has deep experience in technology driven organizations - including fund raising and venture formation, product marketing, product management, business development... View Details
- February 1986 (Revised November 1989)
- Case
Copeland Corp.: Evolution of a Manufacturing Strategy--1975-82 (A)
By: David A. Garvin
Describes the evolution of a company's manufacturing strategy over an eight-year period. Copeland had pursued a strategy of building freestanding focused plants devoted to single processes or product lines, and then moving products from the home plant at Sidney, Ohio... View Details
Keywords: Factories, Labs, and Plants; Product; Production; Strategy; Restructuring; Geographic Location; Manufacturing Industry; Ohio
Garvin, David A. "Copeland Corp.: Evolution of a Manufacturing Strategy--1975-82 (A)." Harvard Business School Case 686-088, February 1986. (Revised November 1989.)
- October 2001
- Supplement
BMW AG: The Digital Auto Project-An Interview With Chris Bangle, Head of Global Design
By: Stefan H. Thomke
Chris Bangle describes how BMW is trying to reduce its development time by half with the aid of computer-aided technologies. To leverage these technologies in the very competitive automotive industry, he talks about how BMW is faced with the challenges of changing its... View Details
Keywords: Interpersonal Communication; Management Practices and Processes; Time Management; Product Development; Organizational Change and Adaptation; Problems and Challenges; Competition; Information Technology; Auto Industry
Thomke, Stefan H. "BMW AG: The Digital Auto Project-An Interview With Chris Bangle, Head of Global Design." Harvard Business School Video Supplement 602-802, October 2001.
- May 1997 (Revised July 1997)
- Case
Vermeer Technologies (F): FrontPage 97
By: Ashish Nanda
Vermeer engineers work at the breakneck pace of "Internet time" to develop the next version of their software product, winning accolades from Microsoft management. Even before this version ships, however, they are faced with another punishing development schedule for... View Details
Keywords: Business Growth and Maturation; Applications and Software; Business Startups; Product Development; Information Technology Industry
Nanda, Ashish, and Georgia Levenson. "Vermeer Technologies (F): FrontPage 97." Harvard Business School Case 397-110, May 1997. (Revised July 1997.)
- 12 Mar 2024
- Cold Call Podcast
How to Bring Good Ideas to Life: The Paul English Story
Keywords: Re: Frances X. Frei
- September 2016 (Revised February 2017)
- Case
Angie's List: Ratings Pioneer Turns 20
By: Robert J. Dolan and Ayelet Israeli
In 1995, before people “googled” or “yelped,” Angela Hicks (HBS, 2000) was establishing her Angie’s List as a pioneer in the accumulation and dissemination of consumer rating information. Hicks focused on the home repair and maintenance market and, as she put it,... View Details
Keywords: Pricing; Pricing Strategy; Services; Product Line Management; Growth; Conjoint Analysis; Market Research; Freemium; Growth Strategy; Two Sided Markets; Ecommerce; Platform; Platform Business; Platform Businesses; Platform Strategy; Platforms; Platforms And Ecosystems; Business Model; Internet and the Web; Business Growth and Maturation; Growth and Development Strategy; Price; Strategy; Digital Platforms; E-commerce; Service Industry; United States
Dolan, Robert J., and Ayelet Israeli. "Angie's List: Ratings Pioneer Turns 20." Harvard Business School Case 517-016, September 2016. (Revised February 2017.)
- January 2020
- Case
Celata Bioinnovations
By: John R. Wells and Benjamin Weinstock
In December 2019, Jon Hu (HBS ‘19) and Dr. Samantha Dale Strasser, co-founders of Celata Bioinnovations, were raising $1 million to launch their company. They had founded Celata less than six months earlier with the aim of redefining the drug discovery process.... View Details
Keywords: Drug Development; Drug Discovery; Drug Trials; Pharmaceutical Companies; Pharmaceutical Company; Pharmaceuticals; Therapeutics; Biologics; Biotech; Biotechnology; Biopharmacy Company; Biochemistry; Technology Commercialization; Technology Companies; Drug Testing; Startup; Start-up; Startups; Start-ups; Startup Financing; Strategic Decision Making; Strategic Decisions; Strategic Evolution; FDA; Food And Drug Administration; Clinical Trials; Disease Management; Market Attractiveness; Market Entry; Market Opportunities; Health Disorders; Technological Innovation; Information Technology; Commercialization; Business Startups; Finance; Decision Making; Strategy; Market Entry and Exit; Opportunities; Pharmaceutical Industry; Biotechnology Industry
Wells, John R., and Benjamin Weinstock. "Celata Bioinnovations." Harvard Business School Case 720-427, January 2020.
- June 2002 (Revised March 2003)
- Case
Bolivia: Globalization, Sovereignty, or Democracy?
By: Rafael M. Di Tella, Huw Pill, Miguel Lopez de Silanes Gomez, Cinthia Fernholz Violand and Ingrid Vogel
Describes the economic stabilization program implemented by the Bolivian government in 1985 to 1986 and its impact on the development process in Bolivia. View Details
Keywords: History; Programs; Development Economics; Inflation and Deflation; Globalization; Government and Politics; Bolivia
Di Tella, Rafael M., Huw Pill, Miguel Lopez de Silanes Gomez, Cinthia Fernholz Violand, and Ingrid Vogel. "Bolivia: Globalization, Sovereignty, or Democracy?" Harvard Business School Case 702-086, June 2002. (Revised March 2003.)
- June 2023
- Article
Gaining Organizational Adoption: Strategically Pacing the Deployment of Digital Innovations
By: Rebecca Karp
Scholars have long suggested that to foster adoption for their innovative products and services, entrepreneurs should engage with customers to better understand their unmet needs. Yet, customers frequently reside in organizations, and organizational members may not be... View Details
Keywords: Entrepreneurship And Strategy; Digital Innovation; Healthcare; Work And Organizations; Organizational Adoption; B2B; Customers; Technology Adoption; Innovation Strategy; Organizational Change and Adaptation
Karp, Rebecca. "Gaining Organizational Adoption: Strategically Pacing the Deployment of Digital Innovations." Academy of Management Journal 66, no. 3 (June 2023): 773–796.
- April, 2023
- Article
Reducing Information Barriers to Solar Adoption: Experimental Evidence from India
By: Meera Mahadevan, Robyn C. Meeks and Takashi Yamano
Off-grid solar technologies hold promise for unelectrified and low-quality electricity settings; however, their adoption remains low. Important barriers to adoption, such as incomplete information remain relatively unexplored in developing countries. In collaboration... View Details
Keywords: Technology Adoption; Renewable Energy; Knowledge Sharing; Developing Countries and Economies; India
Mahadevan, Meera, Robyn C. Meeks, and Takashi Yamano. "Reducing Information Barriers to Solar Adoption: Experimental Evidence from India." Energy Economics 120 (April, 2023).